{"id":"W3171632039","doi":"10.1016/j.jtct.2021.05.004","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Children's Hospital","funders":"National Institutes of Health; Sapienza Università di Roma; CTI Biopharma; Meiji Seika Pharma; Dana-Farber Cancer Institute; Pfizer; CareDx; Government of South Australia; Janssen Pharmaceuticals; Gilead Sciences; Massachusetts General Hospital; Bristol-Myers Squibb; AstraZeneca; Novartis; Amgen; National Cancer Institute; Takeda Pharmaceutical Company","keywords":"Medicine; Clinical trial; Intensive care medicine; Disease; Context (archaeology); Graft-versus-host disease; Systemic therapy; Chronic disease; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.4230951,0.004333915,0.01218036,0.008424259,0.00827096,0.02145058,0.02709666,0.03925493,0.01051847],"category_scores_gemma":[0.4304096,0.006733219,0.01851458,0.01340506,0.0127722,0.008520781,0.01733514,0.04113724,0.01459584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01736349,"about_ca_system_score_gemma":0.09039118,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01312344,"about_ca_topic_score_gemma":0.01782239,"domain_scores_codex":[0.5260422,0.2912319,0.09957572,0.006322929,0.06696714,0.009860006],"domain_scores_gemma":[0.396204,0.3148168,0.06159902,0.03359997,0.1647238,0.02905644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002508658,0.000744926,0.004333439,0.03224674,0.001604831,0.001017839,0.001976565,0.002794908,0.001988386,0.05789753,0.6696444,0.2232418],"study_design_scores_gemma":[0.003758531,0.0006396254,0.01071034,0.05887582,0.001582363,0.001446296,0.00122027,0.003876259,0.002301633,0.03959789,0.8754725,0.0005185556],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003718829,0.1190634,0.1881716,0.3229728,0.04960041,0.1926832,0.01448152,0.004600398,0.104708],"genre_scores_gemma":[0.01249196,0.02152075,0.6961767,0.0968603,0.00580681,0.137874,0.01181413,0.001684489,0.01577082],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.4230951,"threshold_uncertainty_score":0.7114264,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2395835741235416,"score_gpt":0.4655049099569021,"score_spread":0.2259213358333605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}